Analystreport

Selecta Biosciences, Inc. (NASDAQ: SELB) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.

Selecta Biosciences, Inc.  (SELB) 
Last selecta biosciences, inc. earnings: 3/12 08:00 am Check Earnings Report